Carl C. Awh

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

Peter A. Campochiaro, David M. Brown, Carl C. Awh et al. · Ophthalmology · 2011 · 698 citations

Macular Edema, Ocular Disease, Vitreous Body +6

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

David S. Boyer, Andrew N. Antoszyk, Carl C. Awh et al. · Ophthalmology · 2007 · 395 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +7

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Michael Singer, Carl C. Awh, Srinivas R. Sadda et al. · Ophthalmology · 2012 · 355 citations

Ocular Disease, Open-label Extension Trial, Ophthalmology +5

The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh et al. · Ophthalmology · 2019 · 262 citations · Full text